Abstract
A DNA-bridged strategy is used to facilely conjugate streptavidin (STV) to luminescent semiconductor quantum dots (QDs), which leads to convenient and stable QD-DNA-biotin-STV conjugates that serve as fluorescent nanoprobes for ultrasensitive detection of cancer biomarkers with a microfluidic protein chip.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Binding Sites
-
Biomarkers, Tumor / analysis
-
Biotin / chemistry*
-
Carcinoembryonic Antigen / analysis
-
DNA / chemistry*
-
Enzyme-Linked Immunosorbent Assay
-
Fluorescence
-
Microfluidic Analytical Techniques / methods*
-
Microscopy, Atomic Force
-
Particle Size
-
Protein Array Analysis / methods*
-
Quantum Dots*
-
Sensitivity and Specificity
-
Streptavidin / chemistry*
Substances
-
Biomarkers, Tumor
-
Carcinoembryonic Antigen
-
Biotin
-
DNA
-
Streptavidin